Page URL: https://www.bionews.org.uk/page_2519

CRISPR/Cas9

A genome-editing platform that uses an enzyme (Cas9) to make a double-stranded break at a specific location in the genome, directed by a guide RNA.

Articles using this Glossary Item

Page 1 of 7
Genome editing 'cures' mice of HIV infection 8 July 2019 News
Pharma giant teams up with CRISPR experts for drug discovery 17 June 2019 News
Scientist plans to make more genome-edited babies 17 June 2019 News
Gene mutation in genome-edited babies linked to shorter life 10 June 2019 News
Lung-disease gene edited in mice in the womb 29 April 2019 News
Revolutionising reproduction: the future of fertility treatment 25 March 2019 Comment
WHO calls for global human genome editing research registry 25 March 2019 News
China drafts new regulations on 'high risk' biomedical technologies 4 March 2019 News
WHO forms human genome editing panel in wake of controversy 18 February 2019 News
Controversial genome-editing scientist Dr He is alive and under guard 14 January 2019 News
Chinese genome editing cancer trial loses track of patients 7 January 2019 News
Science marches on: key scientific developments in embryo research 7 January 2019 Comment
China halts controversial 'genome-edited babies' research 3 December 2018 News
Birth of first genome-edited babies causes furore 26 November 2018 News
First genome-edited babies: a very different perception of ethics 26 November 2018 Comment
Study suggests 96 percent of people 'immune' to CRISPR/Cas9 5 November 2018 News
New CRISPR tool opens up more of the genome 29 October 2018 News
Genome editing treats inherited liver disease PKU in mice 22 October 2018 News
Japan prepares to allow genome editing in human embryos 8 October 2018 News
Genome editing works in mitochondrial DNA for first time 1 October 2018 News
Page 1 of 7

Events using this Glossary Item

Page 1 of 0